Rapid, Substantial Psoriasis Improvement With Oral IL-23 Inhibitor
(MedPage Today) — ORLANDO — Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an oral peptide targeting interleukin (IL)-23, a randomized study showed.
The primary analysis…
